|
HY-100370-1mL
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-114209-10mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-100mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-25mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-5mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-50mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-1mL
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-119464-10mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-100mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-25mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-5mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-50mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-10mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-100mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-25mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-5mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-50mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-10mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-100mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-5mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-50mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145387-10mg
|
MedChemexpress LLC
|
MRT-81 [CAS 1263132-08-6]
|
|
Cancer-programmed cell death
|
|
|
HY-145387-100mg
|
MedChemexpress LLC
|
MRT-81 [CAS 1263132-08-6]
|
|
Cancer-programmed cell death
|
|
|
HY-145387-25mg
|
MedChemexpress LLC
|
MRT-81 [CAS 1263132-08-6]
|
|
Cancer-programmed cell death
|
|
|
HY-145387-5mg
|
MedChemexpress LLC
|
MRT-81 [CAS 1263132-08-6]
|
|
Cancer-programmed cell death
|
|
